Pivotal Therapeutics Inc. (OCTPK:PVTT.F) announced a non-brokered private placement of 7,500,000 units at a price of CAD 0.21 per unit for gross proceeds of CAD 1,575,000 on November 5, 2015. Each unit consists of one common share and one share purchase warrant. Each warrant entitles the holder to purchase one common share of the company at an exercise price of CAD 0.21 per share for a period of 60 months from the date of closing.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0018 USD | +179,900.00% | -.--% | -.--% |
2016 | Pivotal Therapeutics Inc. Announces Management Changes | CI |
2015 | Ford Teams with Pivotal to Speed Development of Connected Car Experiences Capitalizing on New Ford Sync Connect | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 172K | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+18.33% | 15.33B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B |
- Stock Market
- Equities
- PVTTF Stock
- News Pivotal Therapeutics Inc.
- Pivotal Therapeutics Inc. announced that it expects to receive CAD 1.58 million in funding